labetalol has been researched along with Spinal Diseases in 1 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
Spinal Diseases: Diseases involving the SPINE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Labetalol was effective for inducing hypotension and was not associated with an increase in heart rate, intrapulmonary shunt, or cardiac output as seen with nitroprusside." | 2.67 | A comparison of labetalol and nitroprusside for inducing hypotension during major surgery. ( Azad, SS; Cantillo, J; Goldberg, ME; Huffnagle, S; Marr, AT; McNulty, SE; Seltzer, JL; Torjman, M, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldberg, ME | 1 |
| McNulty, SE | 1 |
| Azad, SS | 1 |
| Cantillo, J | 1 |
| Torjman, M | 1 |
| Marr, AT | 1 |
| Huffnagle, S | 1 |
| Seltzer, JL | 1 |
1 trial available for labetalol and Spinal Diseases
| Article | Year |
|---|---|
A comparison of labetalol and nitroprusside for inducing hypotension during major surgery.
Topics: Adult; Anesthesia, General; Double-Blind Method; Drug Evaluation; Female; Ferricyanides; Hemodynamic | 1990 |